Eveready Industries India Ltd
EVEREADYEveready Industries India Ltd's earnings have outrun its stock. EPS grew +108.1% in a year against a −16.4% price move.
The sharpest disagreement: annual EPS moved +108.1% against a −16.4% price move — the market has not yet caught up with the delivery.
The price is in a confirmed uptrend (4 weeks in) while the P/E sits at the 39th percentile of its own 10-year range. Underneath, the last four quarters read improving — profit +1,320.0% year on year, and 114% of the last 3 years' profit arrived as cash. What settles it: whether the price catches up with earnings that have already moved.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Eveready Industries India Ltd trades at ₹343, in a confirmed uptrend and 4 weeks into that stage. That is +1.0% against its own 200-day average. It sits at 37% of a 52-week range of ₹271 to ₹467. On relative strength it is currently behind the NIFTY 500 on a trailing-13-week view (1 week and counting).
Today the stock is in a confirmed uptrend — week 4 of stage 2, confirmed. At ₹343 it trades +1.0% versus its 200-day average and sits at 37% of its 52-week range (₹271–₹467).
Against the market, two honest reads. Cumulative: over the last 10.4 years the stock moved +47% while the NIFTY 500 moved +276% — behind the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (1 week and counting; last ahead the week of 2026-07-24) — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.
Eveready Industries India Ltd trades at 24.9× P/E, mid-range by its own standards (39th percentile). Its long-run median P/E is 28.3×, measured across 10.4 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 24.9× is mid-range by its own standards (39th percentile), against a long-run median of 28.3× measured over 10.4 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
Why the multiple sits where it does: over the past year annual EPS moved +108.1% against a −16.4% price move — earnings outran the price, pushing the multiple DOWN its own range.
The price move, decomposed: over 5y, of the −1.3%/yr price move, ~−20.6%/yr came from earnings growth and ~+19.3 pp from the multiple (expanding); over 10y, of the +3.2%/yr price move, ~+3.8%/yr came from earnings growth and ~−0.6 pp from the multiple (roughly flat). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is unremarkable against its own past, so the story rests on the earnings line underneath it, not the multiple.
Stage: Mixed Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Eveready Industries India Ltd reads as mixed on its fundamental arc. Mixed — the growth curves are steadily positive, but ROCE at 13.0% is below the 15% bar this page requires to call it Consistent. The read is built from 12 quarters across 4 curves, on full evidence.
Why it matters: when the curves disagree, the per-curve reads above matter more than any single verdict.
The latest quarter’s profit carries a one-off item larger than the operating base, so the profit curve is shown but does not vote in the stage call.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +8.2% | +3.1% | +3.1% | +0.9% |
| Profit | +109.8% | +83.1% | — | +9.6% |
| EPS | +108.1% | +83.8% | — | +9.5% |
| Share price | −16.4% | +0.1% | −1.3% | +3.2% |
4-Factor Sector Score
48.3/100 — rank 14 of 36 in Miscellaneous · 90% evidence confidence
Eveready Industries India Ltd scores 48.3 out of 100 against the 36 companies it is compared with in Miscellaneous, ranking 14. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
The four contributions add to the total exactly: 17.6 + 14.9 + 8.1 + 7.7 = 48.3. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Eveready Industries India Ltd reported ₹327 Cr of revenue in the Mar 26 quarter, +9.4% year on year. That is the 6th straight quarter of year-on-year growth. Over 10 years it has compounded at 0.9% a year. The last full year, FY26, came in at ₹1,455 Cr. The last four reported quarters add to ₹1,455 Cr.
FY26 revenue came in at ₹1,455 Cr (+8.2% on the year), capping 10 years at 0.9% compound. The latest quarter (Mar 26) printed ₹327 Cr, +9.4% year on year — the 6th consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +8.3% growth against the decade's 0.9% — the current year is running faster than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +8.2% over the last 4 quarters against +5.2%/yr over the last 8 — stabilising; TTM profit +108.5% vs +61.0%/yr — accelerating.
Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Eveready Industries India Ltd's operating margin is 9.0% in the Mar 26 quarter, +0.0 percentage points against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged 7.0% to 18.0%. The current quarter sits inside that band.
The latest quarter's operating margin is 9.0%, +0.0 pp against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged 7.0%–18.0%.
Why the margin moved: operating margin went +0.0 pp year on year while gross margin went −2.0 pp — the gain came mostly from the gross line: input costs and pricing.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Eveready Industries India Ltd earned ₹142 Cr of net profit in the Mar 26 quarter, +1,320.0% year on year. Full-year FY26 profit was ₹172 Cr. The 10-year compound rate is 9.6%. That is 43.4% of the quarter's revenue. The same quarter a year earlier earned ₹10.0 Cr. 1 of the last 12 reported quarters were loss-making.
Mar 26 profit was ₹142 Cr, +1,320.0% year on year. On the full year, FY26 printed ₹172 Cr (+109.8%), and the 10-year compound rate is 9.6%.
Why profit moved: revenue contributed +9.4% and the margin +0.0 pp — the quarter was revenue-led, with the margin roughly flat.
Pace comparison, last four quarters: profit +287.6% vs revenue +8.3%. Profit is growing faster than sales — fixed costs are being spread over a bigger base, and each extra rupee of revenue drops more to the bottom line.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years 114% of Eveready Industries India Ltd's reported profit arrived as operating cash — the cash follows the profit. In FY26 that was ₹83.0 Cr of operating cash against ₹172 Cr of profit. After ₹97.0 Cr of capital spending, ₹−14.0 Cr was left as free cash.
FY26: operating cash of ₹83.0 Cr against reported profit of ₹172 Cr, leaving free cash of ₹−14.0 Cr after ₹97.0 Cr of capital spending. Across the last 3 fiscal years the conversion rate is 114% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Why conversion sits at 114%: the cash cycle stretched 23 days between FY21 and FY26 — more of each rupee of profit waits inside the cycle before arriving.
Router verdict: the bigger cash user is investment — capital spending ran 2.6× depreciation over three years, so the next section's job is to check what that build-out is buying.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Eveready Industries India Ltd's cash conversion cycle runs 69 days in FY26, up from 46 days in FY21. Capital spending ran ₹231 Cr over the last 3 years. At FY26 sales of ₹1,455 Cr each day of that cycle holds about ₹4.0 Cr, so roughly ₹275 Cr sits inside the business at any moment.
FY26: debtors at 29 days, inventory at 134 days — roughly 4.4 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of 69 days, looser than FY21's 46.
The full loop: cash goes out to suppliers and production on day 0; stock waits 134 days to sell; customers pay about 29 days after that; and suppliers themselves are paid at 94 days — netting out to the 69-day cycle.
In money terms: at FY26 sales of ₹1,455 Cr, each day of the cycle holds about ₹4.0 Cr — so the 69-day loop keeps roughly ₹275 Cr sitting inside the business at any moment.
On the investment side: capital spending of ₹231 Cr over the last 3 fiscal years against ₹90.0 Cr of depreciation — the company is building well ahead of wear-and-tear. Capital work-in-progress stands at ₹176 Cr (FY26) — capacity paid for but not yet earning.
The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.
Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.
Eveready Industries India Ltd earns a ROCE of 17% in FY26. That is up from a trough of 6% in FY14. Return on invested capital clears the cost of that capital by +4.4 percentage points, so growth here adds value rather than only size. The wiring behind it is 11.8% net margin on 1.20× asset turns.
FY26 ROCE is 17%, recovered from a FY14 trough of 6% — the full ladder below shows the fall and the climb, undoctored.
Why the return is what it is — the wiring (FY26): 11.8% net margin × 1.20× asset turns × 1.95× balance-sheet leverage ≈ 27.6% on equity. Margin does its share; leverage is a meaningful part of the equation.
The capstone test — ROIC − WACC: 16.4% − 12.0% = a +4.4 pp spread. The 12.0% is a standing assumption for the cost of capital in India, not a per-stock estimate — read the sign and the size of the spread, not the decimals. Positive but thin — value creation with little room for error.
Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.
Eveready Industries India Ltd carries total debt of ₹202 Cr against shareholder equity of ₹623 Cr as of Mar 26, a debt-to-equity of 0.32. On the annual view that ratio went from 1.37 in FY22 to 0.32 in FY26. Read the returns elsewhere on this page with that leverage in mind.
Mar 26: total debt of ₹202 Cr against shareholder equity of ₹623 Cr — a debt-to-equity of 0.32. On the annual view, debt-to-equity went from 1.37 (FY22) to 0.32 (FY26). Read the returns on this page with that leverage in mind.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
Foreign institutions added 1.8 points of Eveready Industries India Ltd over 8 quarters, the biggest move on the register. That takes foreign institutions to 5.4% of the company. Promoters moved +0.4 points over the same window, to 43.6%. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — Foreign institutions: +1.8 points over 8 quarters to 5.4%; Promoters: +0.4 points over 8 quarters to 43.6%; Domestic institutions: +0.3 points over 8 quarters to 2.8%.
Why the register moved: foreign institutions drove it (+1.8 points) — steady accumulation by institutions reading the same numbers this page reads.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Eveready Industries India Ltd: the Z-score reads 4.61. A Z-score above roughly 3 reads as safe and below roughly 1.8 as the distress zone, so this sits well clear of distress. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure.
Why it matters: a Z-score of 4.61 sits well clear of the distress zone — the balance sheet is not the risk here.
The safety line in one sentence: the Z-score reads 4.61.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1IIRM Holdings India Ltd526530 | 66.2/100Favorable setup71% evidence | LEADER | 17.7/35 Revenue 14.9% · PAT 12.7% · OPM change 8.4 pp 83% evidence | 19.1/25 ROCE 20.4% · OPM 24.8% 76% evidence | 9.7/20 P/E 40.4× · PEG — 15% evidence | 19.7/20 RS sector 49.6% · RS bench 53.5% · 1Y 67.5%12 of 12 weeks ahead 100% evidence |
| Exact sum: 17.7 + 19.1 + 9.7 + 19.7 = 66.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 2Sagility LtdSAGILITY | 66.1/100Favorable setup87% evidence | TURNING | 24.4/35 Revenue 29.4% · PAT 49.3% · OPM change 0 pp 100% evidence | 15.5/25 ROCE 13.4% · OPM 22% 100% evidence | 14.2/20 P/E 19.8× · PEG 1.05 65% evidence | 12.0/20 RS sector 7.2% · RS bench -5% · 1Y -1.2%0 of 10 weeks ahead 70% evidence |
| Exact sum: 24.4 + 15.5 + 14.2 + 12 = 66.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 3Gulshan Polyols LtdGULPOLY | 65.2/100Favorable setup75% evidence | TURNING | 24.8/35 Revenue 35.2% · PAT 87% · OPM change 4.3 pp 59% evidence | 12.3/25 ROCE 6.3% · OPM 8% 95% evidence | 10.5/20 P/E 28.9× · PEG — 50% evidence | 17.6/20 RS sector 16.1% · RS bench 19.4% · 1Y 16.1%10 of 12 weeks ahead 100% evidence |
| Exact sum: 24.8 + 12.3 + 10.5 + 17.6 = 65.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 4Exhicon Events Media Solutions Ltd543895 | 64.4/100Thin evidence · provisional60% evidence | ASLEEP | 19.3/35 Revenue 100% · PAT 100% · OPM change 0 pp 48% evidence | 20.1/25 ROCE 29.5% · OPM 28% 76% evidence | 13.6/20 P/E 19.2× · PEG — 50% evidence | 11.4/20 RS sector 2.2% · RS bench -1.2% · 1Y -7.8%0 of 10 weeks ahead 70% evidence |
| Exact sum: 19.3 + 20.1 + 13.6 + 11.4 = 64.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 5GMR Airports LtdGMRAIRPORT | 59.8/100Mixed-positive evidence71% evidence | BREAKING OUT | 22.8/35 Revenue 42.2% · PAT 100% · OPM change 2 pp 65% evidence | 14.2/25 ROCE 11.6% · OPM 37% 100% evidence | 8.6/20 P/E 534× · PEG — 15% evidence | 14.2/20 RS sector 3.3% · RS bench 6.5% · 1Y 17.1%9 of 12 weeks ahead 100% evidence |
| Exact sum: 22.8 + 14.2 + 8.6 + 14.2 = 59.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 6Aeroflex Enterprises LtdAEROENTER | 59.3/100Mixed-positive evidence83% evidence | LEADER | 16.8/35 Revenue 20.4% · PAT 4.9% · OPM change 1 pp 83% evidence | 16.0/25 ROCE 12.6% · OPM 18% 95% evidence | 8.1/20 P/E 20.9× · PEG — 50% evidence | 18.4/20 RS sector 24.8% · RS bench 28.1% · 1Y 16%12 of 12 weeks ahead 100% evidence |
| Exact sum: 16.8 + 16 + 8.1 + 18.4 = 59.3 · Decision use: Price leads the evidence: RS versus the benchmark is 28.1%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 7Global Education LtdGLOBAL | 59.3/100Mixed-positive evidence76% evidence | ASLEEP | 16.6/35 Revenue 29.9% · PAT -5.5% · OPM change 7.5 pp 83% evidence | 19.4/25 ROCE 29.2% · OPM 47% 95% evidence | 10.8/20 P/E 20× · PEG — 15% evidence | 12.5/20 RS sector 12.5% · RS bench 15.9% · 1Y 56.5%1 of 12 weeks ahead 100% evidence |
| Exact sum: 16.6 + 19.4 + 10.8 + 12.5 = 59.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 8Take Solutions LtdTAKE | 58.9/100Mixed-positive evidence63% evidence | 25.1/35 Revenue — · PAT 100% · OPM change 2932.2 pp 57% evidence | 8.3/25 ROCE 11.2% · OPM — 80% evidence | 8.5/20 P/E 3222× · PEG — 15% evidence | 17.0/20 RS sector 68% · RS bench 71.4% · 1Y 305.2%11 of 12 weeks ahead to 2026-05-03 100% evidence | |
| Exact sum: 25.1 + 8.3 + 8.5 + 17 = 58.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 9R K Swamy LtdRKSWAMY | 58.5/100Mixed-positive evidence61% evidence | TURNING | 22.5/35 Revenue 15.9% · PAT 21.1% · OPM change 3 pp 83% evidence | 16.9/25 ROCE 12.3% · OPM 22% 95% evidence | 10.4/20 P/E 21.2× · PEG — 15% evidence | 8.7/20 RS sector — · RS bench -11.2% · 1Y —3 of 3 weeks ahead 25% evidence |
| Exact sum: 22.5 + 16.9 + 10.4 + 8.7 = 58.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 10Jai Corp LtdJAICORPLTD | 57.6/100Mixed-positive evidence70% evidence | ASLEEP | 24.1/35 Revenue -0.6% · PAT 100% · OPM change 5 pp 83% evidence | 15.3/25 ROCE 13.3% · OPM 13% 95% evidence | 11.5/20 P/E 10.4× · PEG — 15% evidence | 6.7/20 RS sector -8.2% · RS bench -18.9% · 1Y -1.9%4 of 10 weeks ahead 70% evidence |
| Exact sum: 24.1 + 15.3 + 11.5 + 6.7 = 57.6 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -8.2% and the one-year return is -1.9%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 11Aegis Vopak Terminals LtdAEGISVOPAK | 56.0/100Thin evidence · provisional56% evidence | TURNING | 21.4/35 Revenue 25.6% · PAT 76.7% · OPM change 2 pp 83% evidence | 13.4/25 ROCE 7.6% · OPM 74% 76% evidence | 9.1/20 P/E 104× · PEG — 15% evidence | 12.1/20 RS sector — · RS bench 22% · 1Y 13%5 of 10 weeks ahead 25% evidence |
| Exact sum: 21.4 + 13.4 + 9.1 + 12.1 = 56 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 12Parin Enterprises LtdPARIN | 54.3/100Mixed-positive evidence63% evidence | BREAKING OUT | 19.7/35 Revenue 100% · PAT 100% · OPM change -3 pp 48% evidence | 11.7/25 ROCE 10.8% · OPM 9% 95% evidence | 9.0/20 P/E 123× · PEG — 15% evidence | 13.9/20 RS sector 13.1% · RS bench 16.5% · 1Y 94.6%7 of 12 weeks ahead 100% evidence |
| Exact sum: 19.7 + 11.7 + 9 + 13.9 = 54.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 13Inox Green Energy Services LtdINOXGREEN | 50.7/100Mixed-positive evidence65% evidence | ASLEEP | 24.7/35 Revenue 24.6% · PAT 100% · OPM change 0.5 pp 83% evidence | 9.5/25 ROCE 8.4% · OPM -4.1% 76% evidence | 9.3/20 P/E 66× · PEG — 15% evidence | 7.2/20 RS sector -8.6% · RS bench -8.4% · 1Y -1.1%6 of 10 weeks ahead 70% evidence |
| Exact sum: 24.7 + 9.5 + 9.3 + 7.2 = 50.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 14Eveready Industries India Ltdthis pageEVEREADY | 48.3/100Mixed-negative evidence90% evidence | TURNING | 17.6/35 Revenue 8.2% · PAT 100% · OPM change 0 pp 88% evidence | 14.9/25 ROCE 17.2% · OPM 9% 100% evidence | 8.1/20 P/E 24.9× · PEG 2.1 100% evidence | 7.7/20 RS sector -9.5% · RS bench -3% · 1Y -19.9%4 of 10 weeks ahead 70% evidence |
| Exact sum: 17.6 + 14.9 + 8.1 + 7.7 = 48.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 15TCC Concept LtdTCC | 47.3/100Mixed-negative evidence81% evidence | ASLEEP | 17.3/35 Revenue 100% · PAT 51.1% · OPM change -45 pp 95% evidence | 11.4/25 ROCE 5.7% · OPM 36% 95% evidence | 14.1/20 P/E 20.9× · PEG — 50% evidence | 4.5/20 RS sector -17.6% · RS bench -35% · 1Y -44.2%0 of 11 weeks ahead 70% evidence |
| Exact sum: 17.3 + 11.4 + 14.1 + 4.5 = 47.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 16GKW LtdGKWLIMITED | 46.7/100Mixed-negative evidence63% evidence | ASLEEP | 20.7/35 Revenue -2.1% · PAT 87.5% · OPM change 2160.4 pp 83% evidence | 6.7/25 ROCE 0.5% · OPM — 80% evidence | 10.0/20 P/E — · PEG — 0% evidence | 9.3/20 RS sector -0.9% · RS bench -5% · 1Y -8.8%4 of 10 weeks ahead 70% evidence |
| Exact sum: 20.7 + 6.7 + 10 + 9.3 = 46.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 17Prozone Realty LtdPROZONER | 43.4/100Mixed-negative evidence68% evidence | ASLEEP | 21.2/35 Revenue 9.2% · PAT 100% · OPM change 23 pp 62% evidence | 11.2/25 ROCE 6.1% · OPM 34.5% 95% evidence | 9.6/20 P/E 59.4× · PEG — 15% evidence | 1.4/20 RS sector -23% · RS bench -20.5% · 1Y -0.5%2 of 12 weeks ahead 100% evidence |
| Exact sum: 21.2 + 11.2 + 9.6 + 1.4 = 43.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 18Jindal Photo LtdJINDALPHOT | 41.5/100Mixed-negative evidence67% evidence | ASLEEP | 14.6/35 Revenue 100% · PAT -80% · OPM change -1015.9 pp 83% evidence | 5.9/25 ROCE -1.4% · OPM -932.6% 95% evidence | 10.0/20 P/E — · PEG — 0% evidence | 11.0/20 RS sector 6.3% · RS bench -13.8% · 1Y 23.1%0 of 10 weeks ahead 70% evidence |
| Exact sum: 14.6 + 5.9 + 10 + 11 = 41.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 19Aqylon Nexus LtdAQYLON | 41.4/100Thin evidence · provisional54% evidence | ASLEEP | 12.7/35 Revenue 30.8% · PAT -52.5% · OPM change -2377.7 pp 48% evidence | 16.8/25 ROCE 39.2% · OPM — 80% evidence | 8.7/20 P/E 168.9× · PEG — 15% evidence | 3.2/20 RS sector -41.3% · RS bench -74.1% · 1Y -68.5%0 of 10 weeks ahead 70% evidence |
| Exact sum: 12.7 + 16.8 + 8.7 + 3.2 = 41.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 20Kaveri Seed Company LtdKSCL | 41.2/100Mixed-negative evidence82% evidence | ASLEEP | 18.1/35 Revenue 15.9% · PAT 5% · OPM change 3 pp 65% evidence | 12.6/25 ROCE 18.8% · OPM -15% 100% evidence | 5.1/20 P/E 13.6× · PEG 2.98 100% evidence | 5.4/20 RS sector -17.2% · RS bench -18.7% · 1Y -30.4%5 of 11 weeks ahead 70% evidence |
| Exact sum: 18.1 + 12.6 + 5.1 + 5.4 = 41.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 21TruAlt Bioenergy LtdTRUALT | 40.8/100Mixed-negative evidence63% evidence | ASLEEP | 11.1/35 Revenue 1.8% · PAT -8.1% · OPM change 7 pp 100% evidence | 9.4/25 ROCE 10.8% · OPM 21% 100% evidence | 10.3/20 P/E 23.2× · PEG — 15% evidence | 10.0/20 RS sector — · RS bench — · 1Y —8 of 12 weeks ahead 0% evidence |
| Exact sum: 11.1 + 9.4 + 10.3 + 10 = 40.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 22Delta Corp LtdDELTACORP | 38.6/100Mixed-negative evidence77% evidence | ASLEEP | 11.2/35 Revenue -6.5% · PAT -66.4% · OPM change -5 pp 83% evidence | 9.6/25 ROCE 5% · OPM 17% 95% evidence | 12.5/20 P/E 18.9× · PEG — 50% evidence | 5.3/20 RS sector -18.1% · RS bench -11.6% · 1Y -28.9%6 of 10 weeks ahead 70% evidence |
| Exact sum: 11.2 + 9.6 + 12.5 + 5.3 = 38.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 23Shipping Corporation of India Land & Assets LtdSCILAL | 33.7/100Adverse evidence68% evidence | ASLEEP | 15.6/35 Revenue 27.3% · PAT 100% · OPM change -284.4 pp 62% evidence | 4.7/25 ROCE 1.3% · OPM -349.6% 95% evidence | 9.2/20 P/E 66.6× · PEG — 15% evidence | 4.2/20 RS sector -15.5% · RS bench -12.7% · 1Y -19.8%3 of 12 weeks ahead 100% evidence |
| Exact sum: 15.6 + 4.7 + 9.2 + 4.2 = 33.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 24Unitech LtdUNITECH | 32.0/100Adverse evidence65% evidence | ASLEEP | 12.8/35 Revenue 59% · PAT 5% · OPM change -584 pp 62% evidence | 6.1/25 ROCE 0.1% · OPM 184% 95% evidence | 10.0/20 P/E — · PEG — 0% evidence | 3.1/20 RS sector -27.3% · RS bench -24.8% · 1Y -42.1%3 of 12 weeks ahead 100% evidence |
| Exact sum: 12.8 + 6.1 + 10 + 3.1 = 32 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 25Stanley Lifestyles LtdSTANLEY | 31.5/100Adverse evidence70% evidence | TURNING | 8.4/35 Revenue -1.6% · PAT -55.5% · OPM change -5.2 pp 83% evidence | 10.3/25 ROCE 6.4% · OPM 14.9% 95% evidence | 9.5/20 P/E 62.7× · PEG — 15% evidence | 3.3/20 RS sector -43.7% · RS bench -23.7% · 1Y -53.6%3 of 10 weeks ahead 70% evidence |
| Exact sum: 8.4 + 10.3 + 9.5 + 3.3 = 31.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 26RattanIndia Enterprises LtdRTNINDIA | 29.3/100Adverse evidence62% evidence | ASLEEP | 13.8/35 Revenue 5.4% · PAT -80% · OPM change 19 pp 65% evidence | 1.6/25 ROCE -4.8% · OPM -6% 100% evidence | 10.0/20 P/E — · PEG — 0% evidence | 3.9/20 RS sector -32.1% · RS bench -23% · 1Y -45%6 of 10 weeks ahead 70% evidence |
| Exact sum: 13.8 + 1.6 + 10 + 3.9 = 29.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 27Embassy Developments LtdEMBDL | 26.2/100Adverse evidence68% evidence | BREAKING OUT | 4.3/35 Revenue -20.6% · PAT -80% · OPM change -76.9 pp 83% evidence | 3.6/25 ROCE -2.4% · OPM -76% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 8.3/20 RS sector -17.2% · RS bench -14.6% · 1Y -45.6%8 of 12 weeks ahead 100% evidence |
| Exact sum: 4.3 + 3.6 + 10 + 8.3 = 26.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 28Central Mine Planning & Design Institute LtdCMPDI | 62.2/100Thin evidence · provisional38% evidence | TURNING | 22.3/35 Revenue — · PAT — · OPM change 8 pp 32% evidence | 19.8/25 ROCE 38.1% · OPM 30% 95% evidence | 10.1/20 P/E 26.2× · PEG — 15% evidence | 10.0/20 RS sector — · RS bench — · 1Y —3 of 3 weeks ahead 0% evidence |
| Exact sum: 22.3 + 19.8 + 10.1 + 10 = 62.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 29FlySBS Aviation LtdFLYSBS | 54.7/100Thin evidence · provisional41% evidence | TURNING | 15.4/35 Revenue — · PAT — · OPM change -8 pp 26% evidence | 18.9/25 ROCE 32.5% · OPM 21% 95% evidence | 11.4/20 P/E 13.3× · PEG — 15% evidence | 9.0/20 RS sector — · RS bench -6.8% · 1Y 4.4%3 of 10 weeks ahead 25% evidence |
| Exact sum: 15.4 + 18.9 + 11.4 + 9 = 54.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 30Qualitek Labs Ltd544091 | 53.7/100Thin evidence · provisional29% evidence | 17.3/35 Revenue — · PAT — · OPM change -3 pp 7% evidence | 15.0/25 ROCE 11.9% · OPM 26% 76% evidence | 9.8/20 P/E 33.6× · PEG — 15% evidence | 11.6/20 RS sector — · RS bench 9.1% · 1Y — 25% evidence | |
| Exact sum: 17.3 + 15 + 9.8 + 11.6 = 53.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 31Shree Vasu Logistics LtdSVLL | 51.9/100Thin evidence · provisional48% evidence | TURNING | 18.4/35 Revenue — · PAT — · OPM change 2.6 pp 19% evidence | 15.7/25 ROCE 12.9% · OPM 29% 95% evidence | 8.9/20 P/E 144× · PEG — 15% evidence | 8.9/20 RS sector -16.1% · RS bench 5.1% · 1Y -8.1%9 of 10 weeks ahead 70% evidence |
| Exact sum: 18.4 + 15.7 + 8.9 + 8.9 = 51.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 32Maagh Advertising & Marketing Services Ltd543624 | 49.6/100Thin evidence · provisional35% evidence | 18.3/35 Revenue — · PAT — · OPM change 275.6 pp 32% evidence | 9.0/25 ROCE -0.4% · OPM 55.6% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 12.3/20 RS sector — · RS bench 37% · 1Y —7 of 9 weeks ahead to 2025-03-19 25% evidence | |
| Exact sum: 18.3 + 9 + 10 + 12.3 = 49.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 33Indiqube Spaces LtdINDIQUBE | 49.3/100Thin evidence · provisional46% evidence | ASLEEP | 20.9/35 Revenue 36.9% · PAT 23.6% · OPM change 5 pp 62% evidence | 9.6/25 ROCE 6.4% · OPM 62% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 8.8/20 RS sector — · RS bench -9.8% · 1Y -20.2%2 of 10 weeks ahead 25% evidence |
| Exact sum: 20.9 + 9.6 + 10 + 8.8 = 49.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 34Anzen India Energy Yield Plus TrustANZEN | 47.7/100Thin evidence · provisional46% evidence | ASLEEP | 17.4/35 Revenue 76.8% · PAT 100% · OPM change -9 pp 62% evidence | 8.9/25 ROCE 3.3% · OPM 75.5% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 11.4/20 RS sector — · RS bench 5.7% · 1Y 9.6%4 of 10 weeks ahead 25% evidence |
| Exact sum: 17.4 + 8.9 + 10 + 11.4 = 47.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 35Shree Rama Newsprint LtdRAMANEWS | 44.6/100Thin evidence · provisional46% evidence | 14.1/35 Revenue -20% · PAT 69.8% · OPM change -8 pp 40% evidence | 5.7/25 ROCE 1.9% · OPM 8% 71% evidence | 10.0/20 P/E — · PEG — 0% evidence | 14.8/20 RS sector 7.4% · RS bench 10.5% · 1Y 8.8%11 of 12 weeks ahead to 2026-04-19 70% evidence | |
| Exact sum: 14.1 + 5.7 + 10 + 14.8 = 44.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 36Tandhan Industries Ltd512062 | 42.6/100Thin evidence · provisional33% evidence | TURNING | 16.3/35 Revenue — · PAT -80% · OPM change — 50% evidence | 6.3/25 ROCE -0.3% · OPM — 61% evidence | 10.0/20 P/E — · PEG — 0% evidence | 10.0/20 RS sector — · RS bench — · 1Y —4 of 4 weeks ahead 0% evidence |
| Exact sum: 16.3 + 6.3 + 10 + 10 = 42.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Eveready Industries India Ltd's share price today?
Eveready Industries India Ltd trades at ₹343, −16.4% over the past year. The company is valued at ₹2,492 Cr. The stock sits at 37% of its 52-week range of ₹271–₹467, +1.0% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 4 weeks in. — as of 31 July 2026.
What were Eveready Industries India Ltd's latest quarterly results?
Eveready Industries India Ltd reported revenue of ₹327 Cr and net profit of ₹142 Cr for the Mar 26 quarter. Revenue rose 9.4% and profit rose 1,320.0% year on year. Earnings per share were ₹19.50. The operating margin was 9.0%, 0.0 pp higher than a year earlier. — as of 31 July 2026.
What is Eveready Industries India Ltd's revenue?
Eveready Industries India Ltd reported revenue of ₹327 Cr in the Mar 26 quarter, +9.4% year on year. For the full FY26 fiscal year, revenue was ₹1,455 Cr (+8.2%). Over the last 10 years revenue compounded at 0.9% a year. — as of 31 July 2026.
What is Eveready Industries India Ltd's profit?
Eveready Industries India Ltd earned ₹142 Cr of net profit in the Mar 26 quarter, +1,320.0% year on year. Full-year FY26 profit was ₹172 Cr. The operating margin ran 9.0% in the latest quarter. — as of 31 July 2026.
What is Eveready Industries India Ltd's market cap?
Eveready Industries India Ltd's market capitalisation is ₹2,492 Cr at a share price of ₹343. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 31 July 2026.
What is Eveready Industries India Ltd's P/E ratio?
Eveready Industries India Ltd trades at a P/E of 24.9×, at the 39th percentile of its own 10-year range, against a long-run median of 28.3×. This is a comparison with the stock's own history, not a value call — as of 31 July 2026.
Does Eveready Industries India Ltd pay a dividend?
Yes — Eveready Industries India Ltd's dividend payout was 11% of profit in FY26, and it recorded a payout in 6 of its last 13 reported fiscal years. This page holds the payout ratio, not a per-share amount. — as of 31 July 2026.
Is Eveready Industries India Ltd overvalued?
On its own history, Eveready Industries India Ltd looks mid-range against its own history: its P/E of 24.9× sits at the 39th percentile of its 10-year range (long-run median 28.3×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 31 July 2026.
Is Eveready Industries India Ltd growing?
Yes — Eveready Industries India Ltd is growing: latest-quarter revenue +9.4% year on year, profit +1,320.0%, and the margin +0.0 pp at 9.0%. The 10-year compound rates are 0.9% (revenue) and 9.6% (profit). The earnings engine currently reads: improving — as of 31 July 2026.
How is Eveready Industries India Ltd performing?
Eveready Industries India Ltd is in a confirmed uptrend, 4 weeks in. Its latest quarter's revenue rose 9.4% and profit rose 1,320.0% year on year. Against the NIFTY 500 it has been behind on a trailing-13-week view for 1 week. This describes what the data did, not a rating. — as of 31 July 2026.
What stage is Eveready Industries India Ltd in?
Mixed — the growth curves are steadily positive, but ROCE at 13.0% is below the 15% bar this page requires to call it Consistent. The read comes from the last 12 quarters of growth (revenue growth +8.2% latest, profit growth +108.5% latest, eps growth +108.0% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 31 July 2026.
Is Eveready Industries India Ltd in an uptrend?
Yes — the price is in a confirmed uptrend (week 4 of stage 2), trading +1.0% versus its 200-day average and at 37% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 31 July 2026.
Is Eveready Industries India Ltd beating the market?
Not lately — on a trailing-13-week view Eveready Industries India Ltd is currently behind the NIFTY 500 (1 week and counting; last ahead the week of 2026-07-24), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.4 years the stock moved +47% against the NIFTY 500's +276% — behind the index over the full window. — as of 31 July 2026.
Will Eveready Industries India Ltd's share price go up?
This page publishes no price forecast for Eveready Industries India Ltd. What it measures instead: the share price is ₹343, the price is in a confirmed uptrend 4 weeks in. Its P/E of 24.9× sits at the 39th percentile of its own 10-year range. — as of 31 July 2026.
Who owns Eveready Industries India Ltd?
Promoters hold 43.6% of Eveready Industries India Ltd, foreign institutions 5.4%, domestic institutions 2.8% and the public 48.1% (latest quarter). The biggest move on the register over the last two years: Foreign institutions added 1.8 points over 8 quarters. — as of 31 July 2026.
Does Eveready Industries India Ltd have too much debt?
It is moderate — Eveready Industries India Ltd's debt-to-equity is 0.32, and operating profit covers the interest bill 9×. FY26 borrowings were ₹202 Cr against equity of ₹623 Cr. Read the returns on this page with that leverage in mind — as of 31 July 2026.
What is Eveready Industries India Ltd's capex?
Eveready Industries India Ltd spent ₹231 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹97.0 Cr, with ₹176 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 31 July 2026.
What is Eveready Industries India Ltd's cash flow?
Eveready Industries India Ltd generated ₹83.0 Cr of operating cash flow in FY26 and ₹−14.0 Cr of free cash flow after ₹97.0 Cr of capital spending. Reported profit that year was ₹172 Cr, so operating cash ran behind profit. Cash-flow resolution for India is annual. — as of 31 July 2026.
Is Eveready Industries India Ltd's profit real cash?
Yes — over the last 3 fiscal years, 114% of Eveready Industries India Ltd's reported profit arrived as operating cash. In FY26, operating cash was ₹83.0 Cr against reported profit of ₹172 Cr. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 31 July 2026.
How financially safe is Eveready Industries India Ltd?
On the balance sheet, the Z-score reads 4.61 — above roughly 3 is safe, below roughly 1.8 is the distress zone. That sits well clear of trouble. — as of 31 July 2026.
Where is Eveready Industries India Ltd in its business cycle?
Eveready Industries India Ltd's FY26 operating margin was 11.0%, against a 13-year band of 7.0%–18.0%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran 9.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 31 July 2026.
What could break the Eveready Industries India Ltd story?
The sharpest disagreement: annual EPS moved +108.1% against a −16.4% price move — the market has not yet caught up with the delivery. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 31 July 2026.
Is Eveready Industries India Ltd a stock worth studying right now?
This is not investment advice. The machine read: Eveready Industries India Ltd's earnings have outrun its stock. EPS grew +108.1% in a year against a −16.4% price move. The sharpest open question: whether the price catches up with earnings that have already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 31 July 2026.